The most important cause of death and disability in the Western world is atherosclerotic coronary artery disease (CAD) and its primary complication-acute myocardial infarction (MI). The long-term objective of this project is to define specific genetic pathways and molecular mechanisms for CAD and MI. The central hypothesis of this proposal is that the pathogenesis of CAD/MI involves functional mutations in key genes that perturb the complex molecular processes involved in CAD/MI. To this end, recently, in a large pedigree with autosomal dominant CAD/MI, we identified a specific MEF2A mutation (21-bp deletion) that appears to be responsible for this family's CAD/MI. Furthermore, we have completed a genome-wide scan for susceptibility genes for CAD/MI in a well characterized U.S. cohort consisting of 1,163 affected persons in 428 multiplex families with premature CAD and MI (average age at onset: 44.4 +/- 9.7 years). Of eight novel significant susceptibility loci detected for MI, linkage to the chromosomal region 1p34-36 showed multipoint allele-sharing P values of <10[-12] (LOD = 11.68). The present proposal is driven by these exciting results.
The specific aims are:
Specific Aim 1 : To map and identify a novel CAD/MI gene using single large families and model-based linkage analysis, and positional cloning. First, we will continue to validate our finding that mutations in MEF2A cause familial CAD/MI by characterizing the MEF2A knockout mice and transgenic mice for phenotype related to CAD/MI. A series of molecular and cell biological experiments are designed to explore the molecular mechanisms of the MEF2A deletion. We will also identify SNPs in MEF2A and determine whether some of the SNPs increase or decrease the risk of common complex CAD/MI by association studies. Secondly, we plan to continue to use model-based linkage analysis and positional cloning to map and identify at least one new CAD/MI gene. We have recruited three large and extended CAD/MI pedigrees that are not linked to MEF2A, and each family has statistically sufficient power (simulated LOD scores of 3.53, 7.22, and 6.62, respectively) to conduct a genome-wide scan of significant linkage to CAD and MI. Furthermore, 16 families of more than four affected individuals have been identified with an average of 27 living siblings and parents per family for this study.
Specific Aim 2 : To identify the susceptibility gene for MI on the chromosomal region 1p34-36. We will focus on the chromosome 1p34-36 MI locus for our follow-up gene discovery effort because this is the most significant linkage identified for MI to date (LOD score of 11.68). We will perform fine mapping, identification of candidate genes, SNP identification and genotyping, family- and sib-based TDT analysis as well as population-based case-control studies to determine whether a specific SNP or haplotype in a candidate gene is associated with MI. The accomplishment of research objectives in this proposal has the potential to have a substantial impact on the understanding of the molecular mechanism of coronary artery disease and myocardial infarction, thereby facilitating better prevention, diagnosis and therapy.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center (P50)
Project #
5P50HL077107-03
Application #
7786003
Study Section
Special Emphasis Panel (ZHL1)
Project Start
Project End
Budget Start
2007-01-01
Budget End
2007-12-31
Support Year
3
Fiscal Year
2007
Total Cost
$525,044
Indirect Cost
Name
Cleveland Clinic Lerner
Department
Type
DUNS #
135781701
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Xu, Huichun; Dorn 2nd, Gerald W; Shetty, Amol et al. (2018) A Genome-Wide Association Study of Idiopathic Dilated Cardiomyopathy in African Americans. J Pers Med 8:
Kim, Dae Joong; Christofidou, Elena D; Keene, Douglas R et al. (2015) Intermolecular interactions of thrombospondins drive their accumulation in extracellular matrix. Mol Biol Cell 26:2640-54
Lauer, Michael S (2014) Personal reflections on big science, small science, or the right mix. Circ Res 114:1080-2
Gao, Hanxiang; Li, Lin; Rao, Shaoqi et al. (2014) Genome-wide linkage scan identifies two novel genetic loci for coronary artery disease: in GeneQuest families. PLoS One 9:e113935
Sossey-Alaoui, Khalid (2013) Surfing the big WAVE: Insights into the role of WAVE3 as a driving force in cancer progression and metastasis. Semin Cell Dev Biol 24:287-97
Tang, W H Wilson; Shrestha, Kevin; Tong, Wilson et al. (2013) Nitric oxide bioavailability and adiponectin production in chronic systolic heart failure: relation to severity of cardiac dysfunction. Transl Res 162:26-33
Stenina-Adognravi, Olga (2013) Thrombospondins: old players, new games. Curr Opin Lipidol 24:401-9
Tang, W H Wilson; Shrestha, Kevin; Wang, Zeneng et al. (2013) Diminished global arginine bioavailability as a metabolic defect in chronic systolic heart failure. J Card Fail 19:87-93
Timur, A A; Murugesan, G; Zhang, L et al. (2012) P2RY1 and P2RY12 polymorphisms and on-aspirin platelet reactivity in patients with coronary artery disease. Int J Lab Hematol 34:473-83
Bhattacharyya, Sanghamitra; Sul, Kristina; Krukovets, Irene et al. (2012) Novel tissue-specific mechanism of regulation of angiogenesis and cancer growth in response to hyperglycemia. J Am Heart Assoc 1:e005967

Showing the most recent 10 out of 120 publications